Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 31 - Medicinal preparations containing organic active ingredients
Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
08/2003
08/28/2003CA2476438A1 Combinations of an alpha-2-delta ligand with a selective inhibitor of cyclooxygenase-2
08/28/2003CA2476437A1 Chemosensitizing with liposomes containing oligonucleotides
08/28/2003CA2476434A1 Method of treating trx mediated diseases
08/28/2003CA2476422A1 Topiramate salts and compositions comprising and methods of making and using the same
08/28/2003CA2476417A1 Azabicyclo-substituted benzoylamides and thioamides for treatment of cns-related disorders
08/28/2003CA2476411A1 Thiazolyl urea compounds for the treatment of cancer
08/28/2003CA2476406A1 Fused pyridazine derivative compounds and drugs containing the compounds as the active ingredient
08/28/2003CA2476402A1 Stabilized pharmaceutical compositions of halofuginone and other quinazolinone derivatives
08/28/2003CA2476394A1 Rna interference mediated inhibition of hiv gene expression using short interfering nucleic acid (sina)
08/28/2003CA2476380A1 Stable compositions comprising tezacitabine
08/28/2003CA2476376A1 Myelination of congenitally dysmyelinated forebrains using oligodendrocyte progenitor cells
08/28/2003CA2476115A1 Mono-ester and asymmetrically substituted di-ester pro-drugs of the dopamine d1 receptor agonists
08/28/2003CA2476112A1 Rna interference mediated inhibition of interleukin gene expression using short interfering nucleic acid (sina)
08/28/2003CA2475923A1 Oral dosage form containing a pde 4 inhibitor as an active ingredient and polyvinylpyrrolidon as excipient
08/28/2003CA2475879A1 Synthesis of quinazolinones
08/28/2003CA2475864A1 Novel crystal forms of atorvastatin hemi-calcium and processes for their preparation, as well as novel processes for preparing atorvastatin hemi-calcium forms i, viii and ix
08/28/2003CA2475600A1 Method for producing high-quality hydrophobic licorice extract
08/28/2003CA2475374A1 Use of cyclooxygenase inhibitors and antimuscarinic agents for the treatment of incontinence
08/28/2003CA2475310A1 Antimicrobial streptococcus salivarius strain and use thereof for preventing dental caries
08/28/2003CA2475123A1 Desolvating solvates of atorvastatin hemi-calcium
08/28/2003CA2474848A1 Novel tyloindicines and related processes, pharmaceutical compositions and methods
08/28/2003CA2474785A1 Novel amino acid derivatives, method for production thereof and pharmaceutical compositions comprising said derivative
08/28/2003CA2473133A1 Rrp sequences and knockout mice and uses thereof
08/28/2003CA2473100A1 Pyranones useful as atm inhibitors
08/28/2003CA2473089A1 Piperidin-4-yl urea derivatives and related compounds as chemokine receptor inhibitors for the treatment of inflammatory diseases
08/28/2003CA2468631A1 Prostaglandin composition for the treatment of erectile dysfunction
08/28/2003CA2463438A1 Antipruritics
08/28/2003CA2459793A1 Therapeutic compositions and methods useful in modulating protein tyrosine phosphatases
08/28/2003CA2459532A1 Rna interference by modified short interfering nucleic acid
08/28/2003CA2456444A1 Rna interference mediated inhibition of vascular endothelial growth factor and vascular endothelial growth factor receptor gene expression using short interfering nucleic acid (sina)
08/28/2003CA2455506A1 Rna interference mediated treatment of alzheimer's disease using short interfering nucleic acid (sina)
08/28/2003CA2440190A1 Levothyroxine compositions and methods
08/28/2003CA2419685A1 Antidiabetic agents
08/27/2003EP1338603A1 Novel pyrazole derivatives and diabetes remedies containing the same
08/27/2003EP1338600A1 Fused 1,2,4-Thiadiazine derivatives, their preparation and use
08/27/2003EP1338599A1 Optically pure analogues of Camptothecin
08/27/2003EP1338283A1 Use of neoruscine to treat alopecia
08/27/2003EP1338282A1 Uridine derivatives as Matrix Metalloproteinase (MMP) and Tumor Necrosis Factor (TNF) inhibitors for the treatment of cancer
08/27/2003EP1338281A1 Method for producing an immunotropic antiviral preparation
08/27/2003EP1338280A1 Combination of amines and vanadium (iv)/(v) compounds for the treatment and/or prevention of diabetes mellitus
08/27/2003EP1338279A1 Remedies for keratoconjunctival diseases containing farnesyl acetate as the active ingredient
08/27/2003EP1338278A1 Administration of resveratrol to prevent or treat restenosis following coronary intervention
08/27/2003EP1338274A1 Process for preparing a particulate composition
08/27/2003EP1338271A1 Aqeous solution of ascorbic acid
08/27/2003EP1338270A2 Use of a dihydrochalcone-rich phenolic fraction in a cosmetic composition
08/27/2003EP1338269A1 Composition for whitening the skin and alleviating of pigmentation disorders containing creatinine and/or a creatinine derivative as active ingredient
08/27/2003EP1337859A1 Selective anxiolytic therapeutic agents
08/27/2003EP1337854A2 Method for screening anti-proliferative compounds and inhibiting tumor growth
08/27/2003EP1337850A1 Method for diagnosing a tumor in a patient determining the concentration of pibf
08/27/2003EP1337664A2 Method for introducing antisense oligonucleotides into eucaryotic cells
08/27/2003EP1337640A2 NOVEL RETINA-SPECIFIC HUMAN PROTEINS C7orf9, C12orf7, MPP4 AND F379
08/27/2003EP1337632A2 Differentiated cells suitable for human therapy
08/27/2003EP1337560A2 Truncated cd200
08/27/2003EP1337558A2 A "bach" g protein coupled receptor polypeptide and polynucleotide encoding this receptor
08/27/2003EP1337540A2 Motilide compounds
08/27/2003EP1337539A2 Linkable sialyl lewis x analogs
08/27/2003EP1337535A2 Benzodiazepine derivatives as gaba a receptor modulators
08/27/2003EP1337532A2 Compound for chelating a metal, radiopharmaceutical, manufacturing process therefor, and diagnostic kit
08/27/2003EP1337530A1 Oxazolidinones having a benzannulated 6-or 7-membered heterocycle as antibacterial agents
08/27/2003EP1337529A2 Heterocyclylalkyl piperidine derivatives, their preparation and compositions containing same
08/27/2003EP1337528A2 Benzothiophene derivative compounds, process of preparation and use thereof
08/27/2003EP1337527A1 Indolylmaleimide derivatives as protein kinase c inhibitors
08/27/2003EP1337526A1 Substituted imidazoles useful in the treatment of inflammatory diseases
08/27/2003EP1337525A1 Process for the crystallization of (r)- or (s)-lansoprazole
08/27/2003EP1337524A1 Substituted quinolines as antitumor agents
08/27/2003EP1337523A2 2,4-substituted pyridine derivatives
08/27/2003EP1337522A1 0ovel farnesyl protein transferase inhibitors
08/27/2003EP1337521A1 Salts of an isothiazole-4-carboxamide and their use as anti-hyperproliferation agents
08/27/2003EP1337518A1 Piperazinylpyrazines compounds as antagonists of serotonin 5-ht2 receptor
08/27/2003EP1337517A1 Pyrimidinone derivatives and their use in the treatment of atherosclerosis
08/27/2003EP1337514A1 Method of preparation of (s)-n-tert-butyl-1,2,3,4-tetrahydroisoquinoline-3-carboxamide
08/27/2003EP1337513A1 4-substituted quinolines as antitumor agents
08/27/2003EP1337512A1 (4-acylaminopiperidin-1-yl) acetamides as neurokinin antagonists
08/27/2003EP1337511A1 Bis-heterocyclic compounds with antitumour and chemosensitising activity
08/27/2003EP1337510A2 Synthesis and antimicrobial activityof novel dicationic "reversed amidines"
08/27/2003EP1337508A1 Preparation of sodium-hydrogen exchanger type-1 inhibitors
08/27/2003EP1337504A2 Novel polyamine analog-amino acid conjugates useful as anticancer agents
08/27/2003EP1337285A1 Implants with a phosphazene-containing coating
08/27/2003EP1337283A1 Methods of treating vascular diseases characterized by nitric oxide insufficiency
08/27/2003EP1337279A1 Sterilisation of pharmaceuticals
08/27/2003EP1337276A2 Artery smooth muscle- and vein smooth muscle-specific proteins and uses therefor
08/27/2003EP1337275A1 Methods for enhancing the efficacy of cytotoxic agents through the use of hsp90 inhibitors
08/27/2003EP1337274A2 Hydroxyapatite-targeting poly(ethylene glycol) and related polymers
08/27/2003EP1337273A2 Pharmaceutical formulations comprising paclitaxel, derivatives, and pharmaceutically acceptable salts thereof
08/27/2003EP1337272A2 Combination of gaba agonists and aldose reductase inhibitors
08/27/2003EP1337271A2 Combination of gaba agonists and sorbitol dehydrogenase inhibitors
08/27/2003EP1337269A2 Association of calpain inhibitors and reactive oxygen species trapping agents
08/27/2003EP1337264A1 A nutritional dietary system, formulation, kit and method for use in preparing an individual for a predetermined activity
08/27/2003EP1337263A1 A composition or rose hip and fish oil for alleviating joint pain and stiffness
08/27/2003EP1337262A2 Improved ophthalmic and contact lens solutions with a peroxide source and a cationic polymeric preservative
08/27/2003EP1337261A1 Anti-inflammatory and healing medicine based on laminarin sulphate
08/27/2003EP1337260A1 Preparation for strengthening the immune response in the waldeyer's ring and the oronasal mucosa by intranasal administration
08/27/2003EP1337259A2 Methylenetetrahydrofolate reductase inhibitors and use thereof
08/27/2003EP1337258A1 Methods for inhibiting proliferation of astrocytes and astrocytic tumor cells and uses thereof
08/27/2003EP1337257A1 Use of neuropeptide-y antagonists in treatment of alcoholism
08/27/2003EP1337256A2 Use of thienopyrimidines
08/27/2003EP1337255A2 Use of p38 inhibitors for the treatment of inflammation-enhanced cough
08/27/2003EP1337254A2 Use of weak opioids and mixed opioid agonists/antagonists for treating urinary incontinence
08/27/2003EP1337253A1 Novel compounds
08/27/2003EP1337252A2 Methods of use of fluoroquinolone compounds against pathogenic helicobacter bacteria
1 ... 5362 5363 5364 5365 5366 5367 5368 5369 5370 5371 5372 5373 5374 5375 5376 5377 5378 5379 5380 5381 5382 ... 7860